US Lawmakers Introduce Bill to Restrict Chinese Biotech Investments

US lawmakers are moving forward with a new legislative proposal. The bill aims to curb investments in the Chinese biotech sector. This action is part of a broader effort to manage foreign investments. The legislation targets specific financial flows into Chinese companies. Lawmakers are concerned about national security and technology transfer. The biotech sector is a key area of focus for these restrictions. LatestLY reported on this development in world news and policy. The bill faces further legislative steps before becoming law.